Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Colorcon
Healthtrust
Teva
Accenture
QuintilesIMS
Merck
Moodys
Harvard Business School
McKinsey

Generated: January 20, 2018

DrugPatentWatch Database Preview

RUBRAMIN PC Drug Profile

« Back to Dashboard

When do Rubramin Pc patents expire, and when can generic versions of Rubramin Pc launch?

Rubramin Pc is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in RUBRAMIN PC is cyanocobalamin. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
Summary for RUBRAMIN PC
Drug patent expirations by year for RUBRAMIN PC

US Patents and Regulatory Information for RUBRAMIN PC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb RUBRAMIN PC cyanocobalamin INJECTABLE;INJECTION 006799-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb RUBRAMIN PC cyanocobalamin INJECTABLE;INJECTION 006799-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb RUBRAMIN PC cyanocobalamin INJECTABLE;INJECTION 006799-010 Apr 28, 1988 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
Farmers Insurance
Chinese Patent Office
Merck
Accenture
McKesson
QuintilesIMS
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot